1. Home
  2. KNSA vs ASAI Comparison

KNSA vs ASAI Comparison

Compare KNSA & ASAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • ASAI
  • Stock Information
  • Founded
  • KNSA 2015
  • ASAI 1974
  • Country
  • KNSA United Kingdom
  • ASAI Brazil
  • Employees
  • KNSA N/A
  • ASAI N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • ASAI Food Chains
  • Sector
  • KNSA Health Care
  • ASAI Consumer Staples
  • Exchange
  • KNSA Nasdaq
  • ASAI Nasdaq
  • Market Cap
  • KNSA 1.7B
  • ASAI 1.6B
  • IPO Year
  • KNSA 2018
  • ASAI N/A
  • Fundamental
  • Price
  • KNSA $26.79
  • ASAI $6.42
  • Analyst Decision
  • KNSA Strong Buy
  • ASAI Hold
  • Analyst Count
  • KNSA 5
  • ASAI 2
  • Target Price
  • KNSA $33.60
  • ASAI $9.80
  • AVG Volume (30 Days)
  • KNSA 283.3K
  • ASAI 543.6K
  • Earning Date
  • KNSA 10-29-2024
  • ASAI 11-07-2024
  • Dividend Yield
  • KNSA N/A
  • ASAI N/A
  • EPS Growth
  • KNSA N/A
  • ASAI N/A
  • EPS
  • KNSA N/A
  • ASAI 0.09
  • Revenue
  • KNSA $338,930,000.00
  • ASAI $12,701,923,748.00
  • Revenue This Year
  • KNSA $58.95
  • ASAI $16.24
  • Revenue Next Year
  • KNSA $36.22
  • ASAI $11.05
  • P/E Ratio
  • KNSA N/A
  • ASAI $14.31
  • Revenue Growth
  • KNSA 20.69
  • ASAI 15.85
  • 52 Week Low
  • KNSA $14.12
  • ASAI $5.73
  • 52 Week High
  • KNSA $27.92
  • ASAI $15.25
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 58.67
  • ASAI 43.63
  • Support Level
  • KNSA $23.33
  • ASAI $6.08
  • Resistance Level
  • KNSA $27.35
  • ASAI $6.48
  • Average True Range (ATR)
  • KNSA 0.89
  • ASAI 0.24
  • MACD
  • KNSA 0.15
  • ASAI 0.10
  • Stochastic Oscillator
  • KNSA 86.07
  • ASAI 93.71

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About ASAI Sendas Distribuidora S A ADS

Sendas Distribuidora SA is involved in the consumer goods business. Its cash and carry operations involve sales of more than 8,000 items of grocery, food, perishable, beverage, wrapping, hygiene, and cleaning products, among others. Its customers include prepared food retailers (including restaurants, pizzerias, and snack bars), end-users (including schools, small businesses, religious institutions, hospitals, and hotels), conventional retailers such as grocery stores and neighborhood supermarkets, and individuals. Its stores are located throughout 23 Brazilian states.

Share on Social Networks: